Risk Factors for Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 12 4 2019
medline: 27 6 2019
entrez: 12 4 2019
Statut: ppublish

Résumé

To investigate factors associated with cystoid macular edema (CME) after Descemet membrane endothelial keratoplasty (DMEK) in Asian eyes. In this retrospective, interventional, consecutive case series, 77 eyes of 65 patients who underwent DMEK were evaluated; in 53 eyes, cataract surgery was performed 1 month before DMEK (staged DMEK), and 24 eyes underwent DMEK alone (simple DMEK). Central retinal thickness, incidence of CME, postoperative best-corrected visual acuity, central corneal thickness, and corneal endothelial cell density were assessed at 1, 3, and 6 months after surgery. Multiple regression analysis and stepwise variable selection were performed for parameters such as type of surgery, iris damage scores, age, sex, axial length, preoperative visual acuity, rebubbling, air volume in the anterior chamber on postoperative day 1, history of diabetes, and endothelial cell density loss rates at 6 months after surgery. CME occurred in 12 (15.6%) of 77 eyes. There was no significant difference in best-corrected visual acuity between eyes with and without CME (P = 0.27). Multivariable analysis revealed that the difference in iris damage scores between before and after DMEK (P < 0.001), air volume in the anterior chamber (P = 0.012), simple DMEK (P = 0.020), and rebubbling (P = 0.036) were significantly associated with CME. Stepwise variable selection indicated that iris damage (P < 0.001) was the most important risk factor for CME. Iris damage due to DMEK might be a possible risk and aggravating factor for the development of CME after DMEK. Surgeons should attempt to minimize damage to the iris.

Identifiants

pubmed: 30973407
doi: 10.1097/ICO.0000000000001950
pmc: PMC6571176
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

820-824

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Int Ophthalmol Clin. 2002 Winter;42(1):1-11
pubmed: 12189605
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S203-18
pubmed: 12204717
Cornea. 2011 May;30(5):580-7
pubmed: 21598430
Ophthalmologica. 2012;227(1):20-33
pubmed: 21952101
Ophthalmology. 2014 Oct;121(10):1915-24
pubmed: 24935281
Br J Ophthalmol. 2015 Jan;99(1):98-102
pubmed: 25138759
Ophthalmology. 2015 Nov;122(11):2159-68
pubmed: 26123091
Am J Ophthalmol. 2016 Mar;163:174-179.e2
pubmed: 26701270
Sci Rep. 2016 Apr 28;6:25276
pubmed: 27121659
Cornea. 2016 Aug;35(8):1040-4
pubmed: 27158809
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):5954-5962
pubmed: 27820951
Ophthalmology. 2017 Apr;124(4):572-573
pubmed: 27986384
Cornea. 2017 Mar;36(3):390-393
pubmed: 28002113
BMC Ophthalmol. 2017 Feb 20;17(1):16
pubmed: 28219426
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO42-BIO51
pubmed: 28475702
Sci Rep. 2017 Aug 7;7(1):7412
pubmed: 28785053
Ophthalmology. 2017 Dec;124(12):e86
pubmed: 29157434
Cornea. 2018 Mar;37(3):277-282
pubmed: 29298168
Cornea. 2018 Nov;37(11):1355-1359
pubmed: 30004959
Jpn J Ophthalmol. 2018 Nov;62(6):615-620
pubmed: 30255396

Auteurs

Satoru Inoda (S)

Department of Ophthalmology, Jichi Medical University, Tochigi, Japan.

Takahiko Hayashi (T)

Department of Ophthalmology, Jichi Medical University, Tochigi, Japan.
Department of Ophthalmology, Yokohama Minami Kyosai Hospital, Kanagawa, Japan.

Hidenori Takahashi (H)

Department of Ophthalmology, Jichi Medical University, Tochigi, Japan.

Itaru Oyakawa (I)

Department of Ophthalmology, Heart Life Hospital, Okinawa, Japan.
Department of Ophthalmology, Ryukyu University, Okinawa, Japan.

Hideaki Yokogawa (H)

Department of Ophthalmology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Akira Kobayashi (A)

Department of Ophthalmology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Naoko Kato (N)

Department of Ophthalmology, Saitama Medical University, Saitama, Japan.

Hidetoshi Kawashima (H)

Department of Ophthalmology, Jichi Medical University, Tochigi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH